Aramark
ARMK
$42.86
-1.36%
ARAMARK is a global provider of food services, facilities management, and uniform and career apparel, operating primarily in the North American market across sectors such as education, healthcare, sports and entertainment, and business dining. The company is a leading player in the outsourced services industry, distinguished by its long-term client contracts and scale, which provide a degree of revenue stability. The current investor narrative centers on the company's post-pandemic recovery trajectory, with a focus on margin improvement and cash flow generation as it navigates inflationary pressures and seeks to capitalize on the full return of its core client venues and operations.…
ARMK
Aramark
$42.86
Investment Opinion: Should I buy ARMK Today?
Rating: Hold. The core thesis is that ARMK's reasonable forward valuation and recovery momentum are balanced by significant fundamental risks in its low-margin, leveraged business model, making it unsuitable for a clear Buy or Sell recommendation at this juncture.
Supporting evidence includes a forward P/E of 16.26x, which prices in the estimated EPS of $3.49 and appears fair. The stock trades at a low P/S of 0.56x, suggesting a margin of safety on sales. However, profitability metrics are weak (net margin 1.76%, ROE 10.37%), and the balance sheet is leveraged (D/E 1.82). The stock has shown strong relative strength, gaining 20.32% vs. the market over 3 months, but trades near 52-week highs, limiting near-term upside.
The thesis would upgrade to a Buy if the company demonstrates sustained margin expansion above 2% net margin or successfully reduces its debt-to-equity ratio below 1.5, improving the risk profile. It would downgrade to a Sell if quarterly earnings miss estimates, causing the forward P/E to expand above 20x, or if revenue growth stalls amid economic weakness. Based on the current data, the stock appears fairly valued relative to its growth prospects (PEG 1.31) but carries an above-average risk premium due to its financial structure.
Sign up to view all
ARMK 12-Month Price Forecast
The outlook for ARMK is balanced with a slight tilt towards caution. The forward valuation is reasonable if earnings targets are hit, and the technical trend is positive. However, the fundamental profile—characterized by wafer-thin margins and high leverage—imposes a ceiling on upside potential and defines a clear downside risk. The base case of range-bound trading is most probable. The stance would upgrade to bullish on evidence of successful margin expansion and debt management, likely visible in the next two quarterly reports. It would turn bearish on any indication that the estimated EPS of $3.49 is at risk, which would cause the forward P/E to re-rate higher, eliminating its primary appeal.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aramark's 12-month outlook, with a consensus price target around $55.72 and implied upside of +30.0% versus the current price.
Average Target
$55.72
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$34 - $56
Analyst target range
Analyst coverage for ARAMARK is limited, with only 4 analysts providing estimates, which is typical for a mid-cap industrial services company and can lead to higher volatility and less efficient price discovery. The provided data includes revenue and EPS estimates but lacks a consensus price target, Buy/Hold/Sell distribution, and a target price range. The average revenue estimate for the coming period is $25.71 billion, with a range from $25.44 billion to $26.10 billion, indicating a relatively tight band of expectations. The average EPS estimate is $3.49, ranging from $3.44 to $3.56. Without explicit price targets, the implied upside or downside cannot be calculated, making it difficult to gauge overall analyst sentiment as bullish, neutral, or bearish.
Bulls vs Bears: ARMK Investment Factors
The bull case for ARMK is supported by strong technical momentum, a reasonable forward valuation, and its position in a post-pandemic recovery narrative. However, the bear case presents substantial fundamental challenges, primarily the company's extremely low margins and high financial leverage. Currently, the bullish technical momentum and forward valuation discount provide stronger near-term evidence, but the investment debate hinges on a single critical tension: whether the company's operational execution and cost management can deliver the significant earnings growth (implied by the forward P/E) needed to justify the current price, or if the thin-margin, leveraged business model will succumb to economic pressures, triggering a valuation reset. The resolution of this margin vs. growth dynamic will determine the stock's direction.
Bullish
- Strong Post-Pandemic Momentum: The stock has gained 16.32% over the past three months and 21.05% over the past year, significantly outperforming the S&P 500, which declined -4.0% and gained 22.2% over the same periods, respectively. This robust price action reflects investor confidence in the company's recovery trajectory and operational execution.
- Attractive Forward Valuation: The forward P/E of 16.26x represents a significant discount to the trailing P/E of 31.53x, implying the market is pricing in substantial earnings growth. This forward multiple suggests the stock is reasonably valued if the company can meet the consensus EPS estimate of $3.49.
- Low Price-to-Sales Ratio: With a P/S ratio of 0.56x and an EV/Sales of 0.92x, the stock trades at a discount on a sales basis, which could provide a margin of safety. This low multiple reflects the company's thin gross margin of 5.78% but may attract value-oriented investors if margins stabilize or improve.
- Positive Technical Uptrend: The stock is trading at 86% of its 52-week range, near the high of $44.49, indicating strong bullish momentum. A decisive breakout above this key resistance level could signal a continuation of the uptrend and attract further buying interest.
Bearish
- Extremely Thin Operating Margins: The company operates on razor-thin margins, with a gross margin of 5.78% and a net margin of 1.76%. This leaves minimal room for error in a cost-sensitive, inflationary environment and makes profitability highly vulnerable to input cost pressures.
- High Financial Leverage: A debt-to-equity ratio of 1.82 indicates a heavily leveraged balance sheet, which elevates financial risk, especially in a rising interest rate environment. This high leverage constrains financial flexibility and amplifies earnings volatility.
- Elevated Trailing Valuation: The trailing P/E of 31.53x is high for a low-margin industrial services company, suggesting the stock is pricing in near-perfect execution. Any earnings disappointment could lead to a sharp multiple contraction, given the forward P/E expectation of 16.26x.
- Liquidity and Beta Concerns: A current ratio of 0.99 indicates potential liquidity constraints, as current assets barely cover current liabilities. Furthermore, a beta of 1.136 means the stock is approximately 14% more volatile than the market, which is concerning after its recent strong run.
ARMK Technical Analysis
The stock is in a sustained uptrend, evidenced by a 1-year price change of +21.05%. With a current price of $42.55, it is trading approximately 86% of the way through its 52-week range ($29.92 to $44.49), indicating strong momentum but also proximity to a key technical resistance level that could cap near-term gains. Recent momentum has been robust, with the stock gaining 4.14% over the past month and 16.32% over the past three months, significantly outperforming the broader market, which saw declines of -4.28% and -4.0% over the same periods, respectively. This positive short-term momentum aligns with and reinforces the longer-term bullish trend. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $44.49 and support near the 52-week low of $29.92. A decisive breakout above $44.49 would signal a continuation of the bullish trend, while a failure could lead to consolidation. The stock's beta of 1.136 indicates it is approximately 14% more volatile than the market, which investors must factor into risk assessments, especially given the stock's recent strong run.
Beta
1.14
1.14x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$31-$44
Price range past year
Annual Return
+30.6%
Cumulative gain past year
| Period | ARMK Return | S&P 500 |
|---|---|---|
| 1m | +7.8% | +0.5% |
| 3m | +10.1% | -2.1% |
| 6m | +9.0% | +4.0% |
| 1y | +30.6% | +29.5% |
| ytd | +17.2% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARMK Fundamental Analysis
Data not available for a detailed quarterly revenue trajectory analysis, including YoY growth rates and segment performance. The company's profitability metrics show a net margin of 1.76% and a gross margin of 5.78%, indicating it operates on very thin margins, which is characteristic of the capital-intensive food and facilities services industry. The trailing P/E ratio of 31.53x and a forward P/E of 16.26x suggest the market anticipates significant earnings growth to justify the current valuation. The balance sheet carries substantial leverage, with a debt-to-equity ratio of 1.82, which elevates financial risk, particularly in a rising interest rate environment. The current ratio of 0.99 indicates potential liquidity constraints, as current assets barely cover current liabilities. Return metrics are modest, with an ROE of 10.37% and an ROA of 4.01%, reflecting the challenges of generating high returns in a low-margin business model.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARMK Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 31.53x and a forward P/E of 16.26x; the significant discount of the forward multiple implies the market is pricing in a substantial year-ahead earnings growth expectation, aligning with the estimated EPS growth reflected in the PEG ratio of 1.31. A direct peer comparison is not possible as industry average multiples are not provided in the data. However, the Price-to-Sales ratio of 0.56x and EV-to-Sales of 0.92x appear low, potentially suggesting the market assigns a discount for the company's low-margin profile. Historical context for the valuation is unavailable due to missing historical ratios data, preventing an assessment of whether the current P/E is near the top or bottom of its own historical range.
PE
31.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. ARMK's net margin of 1.76% and gross margin of 5.78% are exceptionally thin, leaving the company highly vulnerable to inflation in food and labor costs, which could quickly erase profitability. The balance sheet is leveraged, with a debt-to-equity ratio of 1.82, increasing interest expense risk and limiting strategic flexibility. Furthermore, a current ratio of 0.99 indicates a tight liquidity position where current assets barely cover liabilities, posing a risk if operating cash flow weakens.
Market & Competitive Risks stem from its valuation and economic sensitivity. The stock's trailing P/E of 31.53x is elevated for its sector, creating compression risk if growth expectations are not met. A PEG ratio of 1.31 suggests the stock is fairly valued relative to its growth, leaving little room for error. The company's beta of 1.136 indicates it is more volatile than the market, and its business is cyclical, tied to corporate spending, education budgets, and entertainment attendance, making it sensitive to an economic slowdown.
Worst-Case Scenario involves a combination of a sharp economic downturn and sustained inflation. This would pressure client budgets, reduce volumes, and squeeze already thin margins simultaneously. High leverage would magnify the earnings decline, potentially leading to a credit rating downgrade and refinancing challenges. In this adverse scenario, the stock could realistically re-test its 52-week low of $29.92, representing a downside of approximately -30% from the current price near $42.55. The historical max drawdown of -18.37% provides a reference for volatility, but a fundamental deterioration could drive losses beyond that level.
FAQ
The key risks are, in order of severity: 1) Margin Risk: Gross margins of 5.78% offer no buffer against inflation, threatening the already thin 1.76% net profit. 2) Financial Risk: A debt-to-equity ratio of 1.82 increases interest expense and default risk in a downturn. 3) Economic Sensitivity: As a service provider to cyclical sectors like education and entertainment, revenues are vulnerable to a recession. 4) Valuation Compression: If the anticipated earnings growth (implied by the forward P/E) fails to materialize, the stock's multiple could contract sharply from its current level.
The 12-month forecast presents three scenarios. The base case (60% probability) sees the stock trading between $40 and $44, assuming it meets the consensus EPS of $3.49. The bull case (25% probability) targets $44.49 to $48, driven by earnings beats and margin expansion. The bear case (15% probability) warns of a drop to $29.92-$36 on an earnings miss and multiple compression. The base case is most likely, hinging on the critical assumption that the company can maintain its fragile profitability in the face of ongoing cost pressures.
ARMK sends mixed valuation signals. On a trailing basis, a P/E of 31.53x appears overvalued for a company with a 1.76% net margin. However, the forward P/E of 16.26x and a PEG ratio of 1.31 suggest it is fairly valued relative to its expected growth. The low P/S ratio of 0.56x indicates the market is applying a discount for its low-profitability profile. Overall, the stock is fairly valued based on forward earnings estimates, but it is not cheap enough to compensate for its elevated financial and operational risks, implying the market is pricing in successful execution.
ARMK is a conditional buy, suitable only for investors who can tolerate the risks of a low-margin, leveraged business. The forward P/E of 16.26x is reasonable if the company hits its $3.49 EPS target, offering potential upside to the $44-48 range in a bull case. However, the downside risk to the 52-week low of $29.92 (about -30%) is significant if margins compress or earnings disappoint. It is a good buy for investors confident in management's ability to execute in a stable economic environment, but a poor choice for those seeking safety or high-growth potential.
ARMK is more suitable for a medium-term investment horizon of 1-3 years rather than long-term holding or short-term trading. Its business model does not promise explosive long-term growth, and its beta of 1.136 makes it too volatile for conservative, income-focused long-term portfolios. The current investment thesis is tied to a post-pandemic recovery and margin improvement cycle, which should play out over the next several quarters. Short-term traders can play the technical breakout above $44.49, but the fundamental risks warrant a holding period long enough to validate the earnings trajectory implied by the forward P/E.